<?xml version="1.0" encoding="UTF-8"?>
<clinical_study>
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 23, 2024</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT00931151</url>
  </required_header>
  <id_info>
    <org_study_id>SURPROL 2</org_study_id>
    <nct_id>NCT00931151</nct_id>
  </id_info>
  <brief_title>Effects of Dietary Protein on Undesirable Postprandial Events in Overweight Subjects</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>Dietary protein differing by their amino acid composition could modulate undesirable&#xd;
metabolic and functional responses to a meal rich in saturated fat and sugars. This study&#xd;
aims at examining the specific effects of dairy protein with different cysteine contents&#xd;
on the postprandial undesirables effects elicited by the ingestion of a high fat meal in&#xd;
overweight subjects.</textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial dysfunction</measure>
    <time_frame>0-2-4-6 hours (after meal ingestion)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial inflammation</measure>
    <time_frame>0-0.5-1-1.5-2-3-4-6 hours (after meal ingestion)</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Casein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Protein source in the high fat meal is casein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Milk soluble protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Protein source in the high fat meal are milk soluble protein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alpha lactalbumin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Protein source in the high fat meal is alpha-lactalbumin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Postprandial metabolic and functional measures</intervention_name>
    <description>After ingestion of a high fat meal containing the different protein sources, the subjects&#xd;
undergo a series of measures of endothelial dysfunction and blood and urine sampling for&#xd;
the assessment of proinflammatory cytokines levels and metabolomics determinations.</description>
    <arm_group_label>Alpha lactalbumin</arm_group_label>
    <arm_group_label>Casein</arm_group_label>
    <arm_group_label>Milk soluble protein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>Inclusion Criteria:&#xd;
&#xd;
  -  BMI between 25 and 30&#xd;
&#xd;
  -  Waist circumference > 94 cm&#xd;
&#xd;
Exclusion Criteria:&#xd;
&#xd;
  -  Allergy to milk protein&#xd;
&#xd;
  -  Abusive drug consumption&#xd;
&#xd;
  -  Smoking&#xd;
&#xd;
  -  Hypertension, diabetes&#xd;
&#xd;
  -  High level of physical activity</textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Benamouzig, MD, Ph. D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - HÃ´pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre de recherche sur volontaires</name>
      <address>
        <city>Bobigny</city>
        <zip>93</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <study_first_submitted>July 1, 2009</study_first_submitted>
  <study_first_submitted_qc>July 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2009</study_first_posted>
  <last_update_submitted>August 22, 2011</last_update_submitted>
  <last_update_submitted_qc>August 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement</investigator_affiliation>
    <investigator_full_name>Robert Benamouzig</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
</clinical_study>
